Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma
出版年份 2019 全文链接
标题
Integrated Analysis of Transcriptome and Prognosis Data Identifies FGF22 as a Prognostic Marker of Lung Adenocarcinoma
作者
关键词
-
出版物
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
Volume 18, Issue -, Pages 153303381982731
出版商
SAGE Publications
发表日期
2019-02-01
DOI
10.1177/1533033819827317
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BRAF inhibitors in metastatic non-small cell lung cancer
- (2018) Geòrgia Anguera et al. Journal of Thoracic Disease
- Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer
- (2017) Cristina Pérez-Ramírez et al. SURGICAL ONCOLOGY-OXFORD
- Driver pattern identification over the gene co-expression of drug response in ovarian cancer by integrating high throughput genomics data
- (2017) Xinguo Lu et al. Scientific Reports
- Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study
- (2017) Alison Pearce et al. PLoS One
- Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations
- (2017) Guanhua Rao et al. Scientific Reports
- Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC)
- (2016) Hongxiang Feng et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling
- (2015) W-H Li et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- BRAF Alterations as Therapeutic Targets in Non–Small-Cell Lung Cancer
- (2015) Tu Nguyen-Ngoc et al. Journal of Thoracic Oncology
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
- (2015) M B Schabath et al. ONCOGENE
- TRRUST: a reference database of human transcriptional regulatory interactions
- (2015) Heonjong Han et al. Scientific Reports
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
- (2015) Susan J. Ramus et al. JNCI-Journal of the National Cancer Institute
- The Influence of Health Disparities on Targeting Cancer Prevention Efforts
- (2014) Alan B. Zonderman et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- The VEGF pathway in lung cancer
- (2013) Michalis Alevizakos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non-Small-Cell Lung Cancer
- (2013) Hyun Seok Kim et al. CELL
- PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells
- (2012) Jia-Yu Tan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Fibroblast Growth Factor 22 Is Not Essential for Skin Development and Repair but Plays a Role in Tumorigenesis
- (2012) Monika Jarosz et al. PLoS One
- Mutations in BRIP1 confer high risk of ovarian cancer
- (2011) Thorunn Rafnar et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started